Adalimumab

• Description :

  Adalimumab is a human monoclonal IgG1 antibody targeting tumour necrosis factor α (TNF-α) .

• CAS Number :

  [331731-18-1]

• Product Name Alternative :

  Anti-Human TNF-alpha, Human Antibody

• UNSPSC :

  12352203

• Target :

  Bacterial; TNF Receptor

• Type :

  Inhibitory Antibodies

• Related Pathways :

  Anti-infection; Apoptosis

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Inflammation/Immunology; Cancer

• Assay Protocol :

  https://www.medchemexpress.com/Adalimumab.html

• Purity :

  99.90

• Solubility :

  H2O

• Smiles :

  [Adalimumab]

• Molecular Weight :

  (145.43 kDa)

• References & Citations :

  [1]Ternant D, et al. Pharmacokinetics and concentration-effect relationship of adalimumab in rheumatoid arthritis. Br J Clin Pharmacol. 2015 Feb;79 (2) :286-97.|[2]Oberoi R, et al. Targeting Tumor Necrosis Factor-α with Adalimumab: Effects on Endothelial Activation and Monocyte Adhesion. PLoS One. 2016 Jul 28;11 (7) :e0160145.

• Shipping Conditions :

  Dry Ice

• Storage Conditions :

  Store at -80°C for 2 years

• Scientific Category :

  Inhibitory Antibodies

• Clinical Information :

  Launched